127 related articles for article (PubMed ID: 11063814)
1. Fluorescence in situ hybridization determination of 22q12-q13 deletion in two intracerebral ependymomas.
Rousseau-Merck M; Versteege I; Zattara-Cannoni H; Figarella D; Lena G; Aurias A; Vagner-Capodano AM
Cancer Genet Cytogenet; 2000 Sep; 121(2):223-7. PubMed ID: 11063814
[TBL] [Abstract][Full Text] [Related]
2. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity on chromosome 22 in human ependymomas.
Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas.
Grill J; Avet-Loiseau H; Lellouch-Tubiana A; Sévenet N; Terrier-Lacombe MJ; Vénuat AM; Doz F; Sainte-Rose C; Kalifa C; Vassal G
Cancer Genet Cytogenet; 2002 Jul; 136(2):121-5. PubMed ID: 12237235
[TBL] [Abstract][Full Text] [Related]
8. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
[TBL] [Abstract][Full Text] [Related]
9. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13.
Karakoula K; Suarez-Merino B; Ward S; Phipps KP; Harkness W; Hayward R; Thompson D; Jacques TS; Harding B; Beck J; Thomas DG; Warr TJ
Genes Chromosomes Cancer; 2008 Nov; 47(11):1005-22. PubMed ID: 18663750
[TBL] [Abstract][Full Text] [Related]
10. Molecular cytogenetic studies of pediatric ependymomas.
Kramer DL; Parmiter AH; Rorke LB; Sutton LN; Biegel JA
J Neurooncol; 1998 Mar; 37(1):25-33. PubMed ID: 9525835
[TBL] [Abstract][Full Text] [Related]
11. Involvement of chromosome 22 in ependymomas.
Wernicke C; Thiel G; Lozanova T; Vogel S; Kintzel D; Jänisch W; Lehmann K; Witkowski R
Cancer Genet Cytogenet; 1995 Feb; 79(2):173-6. PubMed ID: 7889515
[TBL] [Abstract][Full Text] [Related]
12. Constitutional de novo t(1;22)(p22;q11.2) and ependymoma.
Park JP; Chaffee S; Noll WW; Rhodes CH
Cancer Genet Cytogenet; 1996 Feb; 86(2):150-2. PubMed ID: 8603343
[TBL] [Abstract][Full Text] [Related]
13. Loss of chromosome 22 and proliferative potential in ependymomas.
Debiec-Rychter M; Biernat W; Zakrzewski K; Krul W; Liberski PP
Folia Neuropathol; 2003; 41(4):191-5. PubMed ID: 14977248
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma.
Weremowicz S; Kupsky WJ; Morton CC; Fletcher JA
Cancer Genet Cytogenet; 1992 Jul; 61(2):193-6. PubMed ID: 1638502
[TBL] [Abstract][Full Text] [Related]
15. Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas.
Zheng PP; Pang JC; Hui AB; Ng HK
Cancer Genet Cytogenet; 2000 Oct; 122(1):18-25. PubMed ID: 11104027
[TBL] [Abstract][Full Text] [Related]
16. Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas.
Slavc I; MacCollin MM; Dunn M; Jones S; Sutton L; Gusella JF; Biegel JA
Int J Cancer; 1995 Aug; 64(4):243-7. PubMed ID: 7657387
[TBL] [Abstract][Full Text] [Related]
17. Loss of chromosome 1 in myxopapillary ependymoma suggests a region out of chromosome 22 as critical for tumour biology: a FISH analysis of four cases on touch imprint smears.
Tamiolakis D; Papadopoulos N; Venizelos I; Lambropoulou M; Nikolaidou S; Bolioti S; Kiziridou A; Manavis J; Alexiadis G; Simopoulos C
Cytopathology; 2006 Aug; 17(4):199-204. PubMed ID: 16879268
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.
Rubio MP; Correa KM; Ramesh V; MacCollin MM; Jacoby LB; von Deimling A; Gusella JF; Louis DN
Cancer Res; 1994 Jan; 54(1):45-7. PubMed ID: 8261460
[TBL] [Abstract][Full Text] [Related]
19. Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2.
Hulsebos TJ; Oskam NT; Bijleveld EH; Westerveld A; Hermsen MA; van den Ouweland AM; Hamel BC; Tijssen CC
Br J Cancer; 1999 Dec; 81(7):1150-4. PubMed ID: 10584875
[TBL] [Abstract][Full Text] [Related]
20. Human ependymomas reveal frequent deletions on chromosomes 6 and 9.
Huang B; Starostik P; Schraut H; Krauss J; Sörensen N; Roggendorf W
Acta Neuropathol; 2003 Oct; 106(4):357-62. PubMed ID: 12898154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
